PEGdA/Gel-PEG-Cys hydrogel was synthesized following previously published procedures with some modulations (Burmania et al., 2003; Xu et al., 2012; Guerra et al., 2017). The IPN prepolymer solution was made of 1% (w/v) Iragcure 2959 photoinitiator, 20% w/v PEGdA and 20% w/v Gel-PEG-Cys dissolved in 1× PBS solution (pH 4.0) with or without the addition of cisplatin (1 mg/mL, pH 4.0). Such crosslinked IPN hydrogels exhibited higher maximum weight swelling ratio, higher water content, significantly lower cumulative gelatin dissolution up to 7 days, and lower gel stiffness compared to physically incorporated gelatin hydrogels (Fu et al., 2012; Xu et al., 2013).
We first prepared various formulations (Table 1) of Gel-PEG-Cys plus PEGdA in order to have a quickly formed IPN hydrogel. 10% or 20% w/v PEGdA solution and 10% or 20% w/v Gel-PEG-Cys solution were prepared in pH 4.0 1× PBS at 37 °C. Then Gel-PEG-Cys solution was mixed with PEGdA solution and 1% w/v Iragcure 2959 photoinitiator via vortexing. 200 μL of hydrogel precursor solution was dropped onto the flat glass slide and subjected to long-wavelength UV (λmax = 365 nm, intensity at 100 mW/cm2) light until it became a solid gel. As shown in Table 1, higher concentrations of PEGdA solution and Gel-PEG-Cys solution could take a shorter time to form a gel. It took within 2 minutes with 20% w/v PEGdA solution and 20% w/v Gel-PEG-Cys solution, which was fit to the following in vivo study.
Formulation table.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.